Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

por Mickisch, Gerald HJ, Schwander, Björn, Escudier, Bernard, Bellmunt, Joaquim, Maroto, José P, Porta, Camillo, Walzer, Stefan, Siebert, Uwe
Publicado 2011